Angiotensin-converting enzyme inhibitors, angiotensin II receptors antagonists, beta-blockers and ivabradine as supportive therapy in pulmonary hypertension: Drug safety and tolerability-Reference-Cited by-同舟云学术

Angiotensin-converting enzyme inhibitors, angiotensin II receptors antagonists, beta-blockers and ivabradine as supportive therapy in pulmonary hypertension: Drug safety and tolerability

Published:2017-10 Issue: Volume:44 Page:e24-e27
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Correale Michele,Zicchino Stefano,Monaco Ilenia,Di Biase Matteo,Brunetti Natale Daniele^ORCID

Publisher

Elsevier BV

Subject

Internal Medicine

Reference28 articles.

1. Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure;Ameri;Heart Fail Rev,2016

2. Respiratory drive in patients with chronic heart failure and central sleep apnea: data from the Daunia Heart Failure registry;Correale;Int J Cardiol,2017

3. Tissue Doppler Imaging predicts central sleep apnea in patients with chronic heart failure: data from the Daunia Registry;Correale;Eur J Clin Investig,2015

4. Additional prognostic value of EAS index in predicting the occurrence of rehospitalizations in chronic heart failure: data from the Daunia Heart Failure registry;Correale;Eur J Clin Investig,2015

5. Lower cardiovascular mortality with atorvastatin and rosuvastatin vs simvastatin: data from “moderate-intensity” statin users in an observational registry on chronic heart failure (Daunia Heart Failure registry);Brunetti;Int J Cardiol,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging role of sacubitril/valsartan in pulmonary hypertension with heart failure;Frontiers in Cardiovascular Medicine;2023-05-18

2. Safety and Efficacy of Enalapril Combined with Metoprolol in Patients of Hypertension Complicated with Coronary Heart Disease: A Randomised Clinical Trial;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2022

3. Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy;Frontiers in Cardiovascular Medicine;2021-11-12

4. Heart Rate Reduction by Ivabradine: Slowly but Surely?;American Journal of Respiratory Cell and Molecular Biology;2020-12